Consolidated Portfolio Review Corp’s BlackRock Health Sciences Trust BME Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-54,522	Closed	-$2.03M	–	82
2025 Q3	$2.03M	Buy	54,522 +15,643	+40%	+$568K	0.26%	99
2025 Q2	$1.42M	Buy	38,879 +10,012	+35%	+$363K	0.2%	121
2025 Q1	$1.12M	Sell	28,867 -3,566	-11%	-$141K	0.18%	129
2024 Q4	$1.23M	Sell	32,433 -10,141	-24%	-$405K	0.19%	122
2024 Q3	$1.79M	Buy	42,574 +2,853	+7%	+$118K	0.4%	63
2024 Q2	$1.62M	Buy	39,721 +22,729	+134%	+$905K	0.38%	69
2024 Q1	$704K	Buy	16,992 +170	+1%	+$7.12K	0.18%	129
2023 Q4	$681K	Buy	16,822 +7,755	+86%	+$296K	0.16%	143
2023 Q3	$355K	Buy	9,067 +2,400	+36%	+$95.5K	0.09%	219
2023 Q2	$271K	Buy	+6,667	New	+$274K	0.06%	253

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Consolidated Portfolio Review Corp's BME Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of BlackRock Health Sciences Trust (BME) in Q4 2025, closing a stake of 54,522 shares — an estimated $2.03M sold.

Consolidated Portfolio Review Corp first reported a position in BME in Q2 2023 and held it in 10 quarters. The position peaked at $2.03M in Q3 2025. 77 funds tracked by Wall St. Rank hold BME as of Q4 2025.

Consolidated Portfolio Review Corp reported no remaining BlackRock Health Sciences Trust position as of Q4 2025 after selling out during the quarter.
Consolidated Portfolio Review Corp sold 54,522 BlackRock Health Sciences Trust shares in Q4 2025, an estimated $2.03M.
Consolidated Portfolio Review Corp first reported a position in BlackRock Health Sciences Trust in Q2 2023 and held it in 10 quarters.
Consolidated Portfolio Review Corp's BlackRock Health Sciences Trust position peaked at $2.03M in Q3 2025.
77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.